Visby Medical raises approximately $55 million in a funding round led by Catalio Capital Management to enhance launch of its at-home STI test.

Jun 17, 2025•6 months ago

Amount Raised

$55 Million

San JoseHealthcare

Investors

John DoerrPitango VenturesBlue Water Life Science AdvisorsCedars Sinai Medical CenterNd CapitalCatalio Capital Management

Description

Visby Medical has raised approximately $55 million, potentially reaching $65 million, in its latest financing round led by Catalio Capital Management. Existing investors also participated, including ND Capital and Cedars Sinai Medical Center. The funding will accelerate the launch of their FDA-authorized at-home Women's Sexual Health Test. New board members will enhance the company's operational capabilities.

Company Information

Company

Visby Medical

Location

3010 N. 1ST STREET

San Jose, California, United States

About

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company developed a proprietary technology platform that is the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious respiratory and sexually transmitted infections.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends